Thick melanomas without lymph node metastases: A forgotten group with poor prognosis
- 1 May 2020
- journal article
- research article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 46 (5) , 918-923
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline UpdateJournal of Clinical Oncology, 2018
- Adjuvant Dabrafenib plus Trametinib in Stage IIIBRAF-Mutated MelanomaNew England Journal of Medicine, 2017
- Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV MelanomaNew England Journal of Medicine, 2017
- Conditional Survival: An Assessment of the Prognosis of Patients at Time Points After Initial Diagnosis and Treatment of Locoregional Melanoma MetastasisJournal of Clinical Oncology, 2017
- Clinical prognostic markers in stage IIIC melanomaJournal of Surgical Oncology, 2017
- Effects of time interval between primary melanoma excision and sentinel node biopsy on positivity rate and survivalEuropean Journal of Cancer, 2016
- Ten-Year Survival after Multiple Invasive Melanomas Is Worse than after a Single Melanoma: a Population-Based StudyJournal of Investigative Dermatology, 2016
- Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2015
- Regression models for relative survivalStatistics in Medicine, 2003
- Thickness, Cross-Sectional Areas and Depth of Invasion in the Prognosis of Cutaneous MelanomaAnnals of Surgery, 1970